| Authors: |
Gray GE; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa Glenda.gray@mrc.ac.za.; South African Medical Research Council, Cape Town, South Africa., Mayer KH; Fenway Health and Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Elizaga ML; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Bekker LG; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Allen M; DAIDS, NIAID, NIH, Washington, DC, USA., Morris L; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Montefiori D; Duke University, Durham, North Carolina, USA., De Rosa SC; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Sato A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Gu N; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Tomaras GD; Duke University, Durham, North Carolina, USA., Tucker T; South African Medical Research Council, Cape Town, South Africa., Barnett SW; Novartis Vaccines, Cambridge, Massachusetts, USA., Mkhize NN; National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa., Shen X; Duke University, Durham, North Carolina, USA., Downing K; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Williamson C; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Pensiero M; DAIDS, NIAID, NIH, Washington, DC, USA., Corey L; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Williamson AL; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa. |
